{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:05:27Z","timestamp":1761919527632,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.clinre.2011.10.008","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T04:21:05Z","timestamp":1323318065000},"page":"209-213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Squamous-cell carcinoma of the anal canal: Room for improvement with targeted therapy"],"prefix":"10.1016","volume":"36","author":[{"given":"Suilane","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo M.","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimery","family":"de Gramont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Tournigand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2011.10.008_bib0005","series-title":"Clinical radiation oncology","first-page":"747","article-title":"Anal carcinoma","author":"Haddock","year":"2000"},{"key":"10.1016\/j.clinre.2011.10.008_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.soc.2003.12.005","article-title":"The etiology and epidemiology of anal cancer","volume":"13","author":"Welton","year":"2004","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.clinre.2011.10.008_bib0015","doi-asserted-by":"crossref","unstructured":"Edge SB et al. AJCC cancer staging handbook. Part III chapter 15. Anus. 7th ed. Springer. pp\u00a0207\u201317, (last modified on 07\/18\/2011).","DOI":"10.1007\/978-0-387-88443-1_15"},{"key":"10.1016\/j.clinre.2011.10.008_bib0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/sj.bjc.6604897","article-title":"The impact of 18-fluorodeoxyglucose positron emission tomography on the staging, management and outcome of anal cancer","volume":"100","author":"de Winton","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clinre.2011.10.008_bib0030","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinre.2011.10.008_bib0035","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1002\/cncr.25188","article-title":"Prognostic factors derived from a prospective database dictate clinical biology of anal cancer. The Intergroup Trial (RTOG 98-11)","volume":"116","author":"Ajani","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clinre.2011.10.008_bib0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro","year":"1974","journal-title":"Dis Colon Rectum"},{"issue":"9034","key":"10.1016\/j.clinre.2011.10.008_bib0045","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(96)03409-5","article-title":"Epidermoid anal cancer: results from the UKCCCR randomized trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2011.10.008_bib0050","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.clinre.2011.10.008_bib0055","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.008_bib0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0360-3016(97)00329-5","article-title":"Time-dose considerations in the treatment of anal cancer","volume":"39","author":"Constantinou","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clinre.2011.10.008_bib0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.6004\/jnccn.2010.0008","article-title":"Radiation therapy advances for treatment of anal cancer","volume":"8","author":"Pepek","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clinre.2011.10.008_bib0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000121362","article-title":"Long-term outcome after combined radiochemotherapy for anal cancer\u2013retrospective analysis of efficacy, prognostic factors and toxicity","volume":"31","author":"Mai","year":"2008","journal-title":"Onkologie"},{"key":"10.1016\/j.clinre.2011.10.008_bib0075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijrobp.2007.12.027","article-title":"Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08","volume":"72","author":"Konski","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clinre.2011.10.008_bib0080","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1200\/jco.2009.27.15_suppl.4033","article-title":"Treatment intensification by induction chemotherapy (ICT) and radiation dose escalation in locally advanced squamous cell anal canal carcinoma (LAAC): definitive analysis of the intergroup ACCORD-03 trial","volume":"27","author":"Conroy","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clinre.2011.10.008_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2004.06.003","article-title":"Treatment of T3 and T4 anal carcinoma with combined chemoradiation and interstitial 192Ir implantation: a 10-year experience","volume":"3","author":"Hwang","year":"2004","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.008_bib0090","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.radonc.2008.04.011","article-title":"The effect of intensity-modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy-related adverse events following chemoradiotherapy of anal cancer","volume":"87","author":"Saarilahti","year":"2008","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.clinre.2011.10.008_bib0095","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2008.08.070","article-title":"Elective clinical target volumes for conformal therapy in anorectal cancer: an RTOG Consensus Panel Contouring Atlas","volume":"74","author":"Myerson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clinre.2011.10.008_bib0100","first-page":"5","article-title":"Metastatic anal cancer: the search for cure","volume":"29","author":"Cummings","year":"2006","journal-title":"Onkologie"},{"key":"10.1016\/j.clinre.2011.10.008_bib0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0002-9343(89)80702-8","article-title":"Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal","volume":"87","author":"Ajani","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.clinre.2011.10.008_bib0110","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00000421-199312000-00017","article-title":"Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous-cell carcinoma of the anal canal","volume":"16","author":"Jaiyesimi","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clinre.2011.10.008_bib0115","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF01605295","article-title":"Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma","volume":"416","author":"Koretz","year":"1990","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"10.1016\/j.clinre.2011.10.008_bib0120","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/bjs.1800771211","article-title":"Epidermal growth factor receptor expression in colorectal cancer","volume":"77","author":"Steele","year":"1990","journal-title":"Br J Surg"},{"key":"10.1016\/j.clinre.2011.10.008_bib0125","first-page":"137","article-title":"Expression of epidermal growth factor in human gastric and colonic carcinomas","volume":"48","author":"Yasui","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinre.2011.10.008_bib0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hed.10224","article-title":"Targeting epidermal growth factor receptor in head and neck cancer","volume":"25","author":"Ford","year":"2003","journal-title":"Head Neck"},{"key":"10.1016\/j.clinre.2011.10.008_bib0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors with tyrosine kinase activity","volume":"61","author":"Ullrich","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.clinre.2011.10.008_bib0140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2011.10.008_bib0145","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.2004.10.182","article-title":"Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor","volume":"22","author":"Saltz","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinre.2011.10.008_bib0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1309\/X4UADHVN317V2XMW","article-title":"Epidermal growth factor receptor expression in anal canal carcinoma","volume":"124","author":"Le","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clinre.2011.10.008_bib0155","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/modpathol.3800608","article-title":"Expression of epidermal growth factor receptor in squamous-cell carcinomas of the anal canal is independent of gene amplification","volume":"19","author":"Alvarez","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.clinre.2011.10.008_bib0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00280-009-1117-3","article-title":"K-ras status in squamous-cell anal carcinoma (SCC): it's time for targeted-oriented treatment?","volume":"65","author":"Zampino","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.clinre.2011.10.008_bib0165","doi-asserted-by":"crossref","unstructured":"Van Damme N, Deron P, Van Roy N, Demetter P, et al. Epidermal growth factor receptor and K-ras status in two cohorts of squamous-cell carcinomas. BMC Cancer 2010;10:189","DOI":"10.1186\/1471-2407-10-189"},{"key":"10.1016\/j.clinre.2011.10.008_bib0170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10350-006-0786-9","article-title":"Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma: report of a case","volume":"50","author":"Phan","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clinre.2011.10.008_bib0175","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000259615","article-title":"Cetuximab-based treatment of metastatic anal cancer: correlation of response with K-ras mutational status","volume":"77","author":"Lukan","year":"2009","journal-title":"Oncology"},{"issue":"Suppl. 20","key":"10.1016\/j.clinre.2011.10.008_bib0180","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1200\/jco.2008.26.15_suppl.4609","article-title":"Phase I study of cetuximab (CET) in combination with 5-fluorouracil (5-FU), cisplatin (CP), and radiotherapy (RT) in patients with locally advanced squamous-cell anal carcinoma (LAAC)","volume":"26","author":"Olivatto","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinre.2011.10.008_bib0190","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bjs.5376","article-title":"Molecular biology of squamous-cell carcinoma of the anus","volume":"93","author":"Gervaz","year":"2006","journal-title":"Br J Surg"},{"issue":"12","key":"10.1016\/j.clinre.2011.10.008_bib0195","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/ijc.23028","article-title":"Signaling. Activation of AKT and nuclear accumulation of wild type TP53 and MDM2 in anal squamous-cell carcinoma","volume":"121","author":"Patel","year":"2007","journal-title":"Int J Cancer"},{"issue":"14","key":"10.1016\/j.clinre.2011.10.008_bib0200","first-page":"7079","article-title":"Deregulation of eIF4E; 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein","volume":"80","author":"Kwang-Jin Oh","year":"2006","journal-title":"J Vitol"},{"issue":"12","key":"10.1016\/j.clinre.2011.10.008_bib0205","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1158\/1940-6207.CAPR-10-0228","article-title":"Rapamycin inhibits anal carcinogenesis in two preclinical animal models","volume":"3","author":"Stelzer","year":"2010","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111003470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740111003470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:13:32Z","timestamp":1761894812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740111003470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S2210740111003470"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2011.10.008","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Squamous-cell carcinoma of the anal canal: Room for improvement with targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2011.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}